• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.70 Up 0.01(1.45%) May 22, 4:02PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 1,054   3,477   6,947  
    Cost of Revenue486  162  8  
    Gross Profit 568   3,315   6,939  
    Operating Expenses
    Research Development9,511  12,461  9,275  
    Selling General and Administrative7,935  6,340  5,973  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (16,878) (15,486) (8,309)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,686  (554)1,284  
    Earnings Before Interest And Taxes(15,192)(16,040)(7,025)
    Interest Expense -   -   -  
    Income Before Tax(15,192)(16,040)(7,025)
    Income Tax Expense2  2  2  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(15,194)(16,042)(7,027)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (15,194) (16,042) (7,027)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (15,194) (16,042) (7,027)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.